(Q38109321)

29 August 2017

title

Alternatives to blood transfusion. (English)

1 reference

29 August 2017

1

Donat R Spahn

1 reference

29 August 2017

Lawrence T Goodnough

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 May 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

381

1 reference

29 August 2017

issue

9880

1 reference

29 August 2017

page(s)

1855-1865

1 reference

Current and emerging infectious risks of blood transfusions

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Adverse blood transfusion outcomes: establishing causation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Anemia and blood transfusion in critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Patient blood management in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Activity-based costs of blood transfusions in surgical patients at four hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Patient blood management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Detection, evaluation, and management of iron-restricted erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Iron deficiency syndromes and iron-restricted erythropoiesis (CME).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Erythropoietin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Bloodless medicine: clinical care without allogeneic blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Transfusion medicine. Second of two parts--blood conservation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

The rise and fall of preoperative autologous blood donation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

A prospective, randomized study of preoperative autologous donation for hip replacement surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Acute normovolemic hemodilution is not beneficial in patients undergoing primary elective valve surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

A controlled trial of intra‐operative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Cell salvage for minimising perioperative allogeneic blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Desmopressin for minimising perioperative allogeneic blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Effects of desmopressin on platelet function under conditions of hypothermia and acidosis: an in vitro study using multiple electrode aggregometry*.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

A comparison of aprotinin and lysine analogues in high-risk cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Current status of pharmacologic therapies in patient blood management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Mechanisms of thrombus formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Management of bleeding and coagulopathy following major trauma: an updated European guideline

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Logistics of transfusion support for patients with massive hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Safety of Recombinant Activated Factor VII in Randomized Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Haemorrhage control in severely injured patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Hepcidin and iron regulation, 10 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Iron Loading and Overloading due to Ineffective Erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Anemia of chronic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primar

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Absence of functional EpoR expression in human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Chapter 4: Red cell transfusion to treat anemia in CKD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Erythropoiesis-stimulating agents--time for a reevaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Treatment of anemia with darbepoetin alfa in systolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Diagnosis of iron-deficiency anemia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960808-9

7 January 2021

10.1016/S0140-6736(13)60808-9

Identifiers

DOI

1 reference

29 August 2017

1 reference